Noramco Group, a North American pharmaceutical supply chain services provider, integrates Noramco, Purisys, and Halo Pharma to improve supply chain performance and increase domestic production. The move addresses drug shortages and quality concerns in the US pharmaceutical industry. The consolidation aims to streamline processes, reduce costs, and enhance regulatory compliance.